The mpn Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the mpn Hub cannot guarantee the accuracy of translated content. The mpn and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The MPN Hub is an independent medical education platform, sponsored by AOP Health and GSK, and supported through an educational grant from Bristol Myers Squibb. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View mpn content recommended for you
Thrombotic and hemorrhagic complications in MPN
Jean-Jacques Kiladjian
John Mascarenhas
Tiziano Barbui
Chloé JamesThe MPN Hub invited Chloe James, University Hospital of Bordeaux, Bordeaux, FR, to give a presentation and chair a discussion on thrombotic and hemorrhagic complications in myeloproliferative neoplasms (MPN). MPN Hub Steering Committee members Jean-Jacques Kiladjian, Tiziano Barbui, and John Mascarenhas also joined the discussion.
James opens with an overview of key components of thrombosis in MPN and current treatment options. She goes on to discuss the prevention of thrombosis and concludes by discussing how to assess bleeding risk. Following this presentation, the committee members discussed this important topic area and provided further insights.
Thrombotic / hemorrhagic complications